BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2859980)

  • 1. [Disorders of noradrenergic pathways in anorexia nervosa. Results].
    Lang F; Estour B; Peyrin L; Perrier B; Digonnet C; Rousset H; Pellet J
    Encephale; 1985; 11(1):13-7. PubMed ID: 2859980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Noradrenergic hypothesis in anorexia nervosa: prospective study using beta-stimulant therapy].
    Lang F; Perrier E; Pellet J
    Ann Med Psychol (Paris); 1983; 141(8):918-25. PubMed ID: 6153059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of dexamethasone suppression test and thyrotropin-releasing hormone test results in different subtypes of depression.
    D'Haenen H; Kaufman L; De Weert D; Cornet C; Raets I
    Acta Psychiatr Belg; 1984; 84(3):228-34. PubMed ID: 6435395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical abnormalities in anorexia nervosa: similarities to affective disorders.
    Gwirtsman HE; Gerner RH
    Biol Psychiatry; 1981 Oct; 16(10):991-5. PubMed ID: 7306620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine measures in anorexia nervosa: comparisons with primary affective disorders.
    Müller EE; Cavagnini F; Panerai AE; Massironi R; Ferrari E; Brambilla F
    Adv Biochem Psychopharmacol; 1987; 43():261-71. PubMed ID: 3035890
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormalities of dexamethasone suppression test and urinary MHPG in anorexia nervosa.
    Gerner RH; Gwirtsman HE
    Am J Psychiatry; 1981 May; 138(5):650-3. PubMed ID: 7235062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited clinical utility of urinary MHPG.
    Lieber AL
    Hillside J Clin Psychiatry; 1988; 10(1):98-104. PubMed ID: 3137145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective study of sulfate and glucuronide conjugates of urinary MHPG in nervous depression. Peripheral and central influences].
    Peyrin L; Pequignot JM; Chauplannaz G; Laurent B; Moindrot J; Aimard G
    Encephale; 1985; 11(1):19-24. PubMed ID: 3996286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical profile of depressed adolescents.
    Khan AU
    J Am Acad Child Adolesc Psychiatry; 1987 Nov; 26(6):873-8. PubMed ID: 3123454
    [No Abstract]   [Full Text] [Related]  

  • 13. The TRH test and urinary MHPG in unipolar depression.
    Sternbach HA; Kirstein L; Pottash AL; Gold MS; Extein I; Sweeney DR
    J Affect Disord; 1983 Aug; 5(3):233-7. PubMed ID: 6224835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of T.R.H. in mental anorexia].
    de Laharpe F; Reville P; Healy JC; Stephan F
    Lille Med; 1976; 21(7):553-7. PubMed ID: 825695
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI; Halaris A; Baxter L; Schwarcz G; Thompson M; Hurwicz ML; Hill M; Young M; Daugherty K; Clemens A
    Psychopharmacol Bull; 1985; 21(1):77-80. PubMed ID: 3920706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anorexia-nervosa--psychopathologic findings in relation to body weight and neuroendocrinologic changes].
    Toifl K; Friedrich MH; Waldhauser F
    Z Kinder Jugendpsychiatr; 1985; 13(2):110-22. PubMed ID: 3939281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics.
    Dackis CA; Pottash AL; Bailey J; Stuckey RF; Extein IL; Gold MS
    NIDA Res Monogr; 1983 Apr; 43():266-72. PubMed ID: 6410260
    [No Abstract]   [Full Text] [Related]  

  • 18. TRH stimulation and dexamethasone suppression in borderline personality disorder.
    De la Fuente JM; Mendlewicz J
    Biol Psychiatry; 1996 Sep; 40(5):412-8. PubMed ID: 8874844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the dexamethasone suppression test in anorexia nervosa].
    Herpertz-Dahlmann B; Remschmidt H
    Monatsschr Kinderheilkd; 1987 Nov; 135(11):758-62. PubMed ID: 3431557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.